- Medical Portal

Asthma Inhaler Case - Bookshelf

Integrated Pharmacy Case Studies
456 pages
Integrated Pharmacy Case Studies

Outline the chemistry of glucocorticoids and b2-adrenoreceptor agonists used in the treatment of asthma . Outline the formulation of pressurised metered-dose inhalers . Describe the use of spacers with pressurised metered-dose inhalers . Outline the formulation of dry powder inhalers . Consider the issues that may affect adherence in asthma, and make appropriate treatment recommendations to improve this Case study Miss GN is a 19-year-old young woman who is currently ...

Clinical Asthma, Theory and Practice
337 pages
Clinical Asthma, Theory and Practice

CONTENTS Dry Powder Inhalers Soft Mist Inhalers Nebulizers Choice of an Inhaler Device for Asthma Therapy Admit Recommendations Conclusions CASE PRESENTATIONS 1. A 45-year-old male with a recent diagnosis of asthma presented for lung function testing. He reported shortness of breath and the lack of effect of his therapy, and he particularly mentioned that he had no symptomatic relief after inhaling salbutamol via a pressurized metered-dose inhaler (pMDI). He said he ...

Clinical Cases: Drug Calculations Case Studies
260 pages
Clinical Cases: Drug Calculations Case Studies

ACM 17, 2009. Canberra: AIHW. Online. Available: WorkArea/DownloadAsset. aspx?id=6442453834 30 June 2015. Australian Institute of Health and Welfare (AIHW): Asthma. 2011. Online. Available: http:// 30 June 2015. McKenna L, Lim AG: McKenna's pharmacology for nursing and health professionals, ed 2, Sydney, 2014, Lippincott Williams & Wilkins. Melani AS, Bonavia M, Cilenti V, et al: Inhaler mishandling remains common in ...

Asthma Asthma

Detailed below is the step wise approach to medical management of asthma. Step 1 — Occasional use of inhaled short-acting beta2 agonists: In case of very mild asthma, your doctor is likely to recommend short-acting bronchodilators such as salbutamol or terbutaline. These medicines are normally used as inhalers to relieve minor symptoms. Beta2 agonists alone are prescribed when its occasional use allows you to lead an active and normal life and you do not suffer from symptoms ...

Blueprints Notes and Cases, Pharmacology
187 pages
Blueprints Notes and Cases, Pharmacology

JC is a 14-year-old boy with a 7-year history of mild-intermittent asthma who complains of SOB, cough, and poor endurance during football practice. Other than this EIB, his asthma has been well controlled for the past several years with only "as needed" p2-agonist therapy for asthma symptoms. He has not needed to use his rescue inhaler (albuterol) for nearly a year. PFTs reveal his FEV, = 95% of predicted. Which of the following is the best treatment for JC? A. Administer albuterol ...

Asthma Inhaler Case - News

Ask Dr. John: Bronchitis and mumps
Ask Dr. John: Bronchitis and mumps I have been noticing a lot of people coughing and having trouble breathing and a few of my friends have come down with bronchitis. Have you noticed or has there been a spike in cases that you have seen? Also, what are some symptoms or bronchitis?

Pharmalot, Pharmalittle: We're Reading About Novartis, Pay-to-Delay and Lots ...
The California Supreme Court heard arguments yesterday in a case that could give the pharmaceutical industry more guidance on the legality of so-called “pay-for-delay” agreements, The Recorder tells us. A class of consumers alleges that Bayer

King v. Burwell: What Republicans Are Really Hoping For
The plaintiffs in this case, and the many Republicans in Congress who are cheering them on, want to eliminate the current tax credits that enable millions of Americans of modest means to buy health insurance. For people with pre-existing conditions

Drug take back to be held March 21
Clean up on sources once contaminated can take years and in some cases clean up may not be possible. What was once commonly believed to be an appropriate manner of disposing of drugs, flushing the medication away, has exacerbated the problem of 

If You 'Want To Make A Good Drug Great' Cost Must Be Factored In
marketed an inhaled insulin product, Exubera, a decade ago, and for a variety of reasons it failed so badly that Pfizer took a $2.6 billion pretax loss. MannKind and Sanofi believe, however, that Afrezza is a superior product and that may prove to